Investigational Site 889 — Troy, Michigan

Investigational Site 889 is a clinical research site located in Troy, Michigan, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site 889 has participated in 1 clinical trials.

Therapeutic areas: Eosinophilic Asthma.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Troy

Browse all research sites in Michigan · View every site in Troy

• William Beaumont Hospital
• William Beaumont Hospital - Troy Cardiology
• William Beaumont Hospital-Troy
• Corewell Health Beaumont Troy Hospital
• Beaumont Hospital, Troy Campus
• William Beaumont Hospitals
• Beaumont Hospital Troy
• William Beaumont Hospital-Troy Campus
• Beaumont Hospital
• Hematology Oncology Consultants PC-Troy
• Arcturus Healthcare, PLC, Troy Internal Medicine Research Division
• Revival Research Institute

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 889?

Investigational Site 889 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 889 conducted?

Investigational Site 889 has 1 clinical trials on record. Their work covers Eosinophilic Asthma.

Is Investigational Site 889 accredited by Crixeo Clinical Trials?

Investigational Site 889 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 889?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.